États-Unis · Bourse & Finance · Morningstar

Celaid Therapeutics Completes Second Close of Series B Financing Round

Publié par Morningstar · États-Unis il y a 8 h

TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the completion…

Lire l'article complet sur Morningstar Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.morningstar.com)

Celaid Therapeutics Completes Second Close of Series B Financing Round

À lire aussi

Zcash gets a Washington lobbyist to push crypto policy

Air Force removes all bombers from British base and redeploys them to the U.S. after a planned terror attack linked to Iran was foiled

Fuel Price Shock Pushes Global Gas Car Sales Below 50% for First Time

U.K. is said to plan tariffs on Chinese EVs under pressure from EU

Supreme Court Justice Alito said he's 'thought about' retirement as Senate control hangs in balance

P.&G.’s Chief on Whether Brand Loyalty Is Enough When Prices Keep Climbing

Celaid Therapeutics Completes Second Close of Series B Financing Round

Partager

À lire aussi

Zcash gets a Washington lobbyist to push crypto policy

Air Force removes all bombers from British base and redeploys them to the U.S. after a planned terror attack linked to Iran was foiled

Fuel Price Shock Pushes Global Gas Car Sales Below 50% for First Time

U.K. is said to plan tariffs on Chinese EVs under pressure from EU

Supreme Court Justice Alito said he's 'thought about' retirement as Senate control hangs in balance

P.&G.’s Chief on Whether Brand Loyalty Is Enough When Prices Keep Climbing